Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

amyloidogenic apolipoprotein A-II, mouse

Known as: apolipoprotein A-II, type C, mouse, apolipoprotein A-II, amyloidogenic, mouse, Apoa2c, mouse 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Apolipoprotein A-II

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
A Consensus Method for the Prediction of ‘Aggregation-Prone’ Peptides in Globular Proteins
The purpose of this work was to construct a consensus prediction algorithm of ‘aggregation-prone’ peptides in globular proteins… Expand
  • table 1
  • figure 1
Highly Cited
2012
Highly Cited
2012
Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Actaea racemosa.
A screen of a library of synthetic drugs and natural product extracts identified a botanical extract that modulates the… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.
OBJECTIVES To explore mechanisms through which altered peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2007
Highly Cited
2007
Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
The abnormal deposition of the amyloid beta-protein (Abeta) in the brain appears crucial to the pathogenesis of Alzheimer's… Expand
Highly Cited
2005
Highly Cited
2005
Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology*
The brains of Alzheimer's disease (AD) patients contain large numbers of amyloid plaques that are rich in fibrils composed of 40… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2005
2005
Characterization of two distinct beta2-microglobulin unfolding intermediates that may lead to amyloid fibrils of different morphology.
The self-assembly of beta(2)-microglobulin into fibrils leads to dialysis-related amyloidosis. pH-mediated partial unfolding is… Expand
Highly Cited
1999
Highly Cited
1999
Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model
Aims/hypothesis. Type II (non-insulin-dependent) diabetes mellitus is a multifactorial disease in which pancreatic islet amyloid… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
1999
1999
Benzolactam (BL) enhances sAPP secretion in fibroblasts and in PC12 cells.
Activation of protein kinase C is known to favor the alpha-secretase processing of the Alzheimer's disease (AD) amyloid precursor… Expand
Highly Cited
1995
Highly Cited
1995
Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides
Acetylcholinesterase (AChE) colocalizes with amyloid-beta peptide (A beta) deposits present in the brain of Alzheimer's patients… Expand
1992
1992
Differential expression of carboxyl terminal derivatives of amyloid precursor protein among cell lines
Understanding the pathway for amyloid precursor protein (APP) catabolism has become an important line of investigation. APP is a… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE